These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3711554)

  • 1. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy.
    Greenberg MA; Kaufman CR; Gonzalez GE; Rosenblatt CD; Smith LJ; Summers RJ
    J Allergy Clin Immunol; 1986 Jun; 77(6):865-70. PubMed ID: 3711554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late systemic-allergic reactions to inhalant allergen immunotherapy.
    Greenberg MA; Kaufman CR; Gonzalez GE; Trusewych ZP; Rosenblatt CD; Summers RJ
    J Allergy Clin Immunol; 1988 Aug; 82(2):287-90. PubMed ID: 3403869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic reactions due to allergen immunotherapy.
    Karaayvaz M; Erel F; Caliskaner Z; Ozangüç N
    J Investig Allergol Clin Immunol; 1999; 9(1):39-44. PubMed ID: 10212856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice.
    Copenhaver CC; Parker A; Patch S
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):441-7. PubMed ID: 22018617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy units: a follow-up study.
    Machín IS; Robaina JCG ; Bonnet C; de Blas C; Fernández-Caldas E; Triviño MS; de la Morin FT
    J Investig Allergol Clin Immunol; 2001; 11(3):167-71. PubMed ID: 11831448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reappraisal of inhalant allergens available for allergy practice in Japan. A need to increase allergen extracts available for immunotherapy].
    Nagaya H
    Arerugi; 1991 Jan; 40(1):60-4. PubMed ID: 2029221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment.
    Mellerup MT; Hahn GW; Poulsen LK; Malling H
    Clin Exp Allergy; 2000 Oct; 30(10):1423-9. PubMed ID: 10998019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts.
    Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
    Clin Exp Allergy; 2007 Mar; 37(3):434-40. PubMed ID: 17359393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse reactions to immunotherapy in pediatric patients].
    Avila Castañón L; Lerma-Ortiz L; Velázquez Armenta Y; del Rio Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2003; 50(5):182-6. PubMed ID: 14631589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective national study of the safety of immunotherapy.
    Vervloet D; Khairallah E; Arnaud A; Charpin J
    Clin Allergy; 1980 Jan; 10(1):59-64. PubMed ID: 7363446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N; Ambriz Moreno Mde J
    Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimising the risks of allergen-specific injection immunotherapy.
    Malling HJ
    Drug Saf; 2000 Oct; 23(4):323-32. PubMed ID: 11051219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal immunotherapy in patients with allergic fungal sinusitis.
    Greenhaw B; deShazo RD; Arnold J; Wright L
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):432-6. PubMed ID: 22018615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic reactions to immunotherapy: influence of composition and manufacturer.
    Gastaminza G; Algorta J; Audicana M; Etxenagusia M; Fernández E; Muñoz D
    Clin Exp Allergy; 2003 Apr; 33(4):470-4. PubMed ID: 12680862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.